Palatin Technologies
PTN
$1.73
Share price
-1.14%
Change (1 day)
-32.42%
Change (1 year)
Categories
Earnings for Palatin Technologies (PTN)
Earnings in 2023 (TTM): -$31.58 M
According to Palatin Technologies's latest financial reports the company's current earnings (TTM) are -$31.58 M. a decrease over its 2022 earnings that were of -$30.59 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Palatin Technologies from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$31.58 M | 3.24% |
| 2022 | -$30.59 M | -13.7% |
| 2021 | -$35.45 M | 33.25% |
| 2020 | -$26.6 M | -172.11% |
| 2019 | $36.88 M | 2352.33% |
| 2018 | $1.5 M | -94.13% |
| 2017 | $25.62 M | -154.92% |
| 2016 | -$46.67 M | 3.67% |
| 2015 | -$45.02 M | 878% |
| 2014 | -$4.61 M | -72.64% |
| 2013 | -$16.83 M | -33.11% |
| 2012 | -$25.15 M | 77.71% |
| 2011 | -$14.16 M | |
| 2003 | -$23.97 M | 29.93% |
| 2002 | -$18.45 M | 36.18% |
| 2001 | -$13.55 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -53,847.30% | 🇺🇸 USA |
 AstraZeneca AZN | $8.49 B | -27,002.15% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | $0.33 B | -1,166.90% | 🇺🇸 USA |
 MediciNova MNOV | -$8.57 M | -72.87% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $64.31 M | -303.68% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -$0.12 B | 272.58% | 🇺🇸 USA |
 ANI Pharmaceuticals ANIP | $19.87 M | -162.93% | 🇺🇸 USA |
 GlycoMimetics
GLYC | -$36.9 M | 16.85% | 🇺🇸 USA |
 Ardelyx ARDX | -$65.52 M | 107.49% | 🇺🇸 USA |